New Postpartum Depression Drug Costs Nearly $16,000

New Postpartum Depression Drug Costs Nearly $16,000

OLATHE, Kan. A new, first-of-its-kind oral pill to treat postpartum depression, which affects 1 in 7 women, comes with a hefty price tag. The U.S. Food and Drug Administration approved Zurzuvae in August, but the company that makes the drug just announced the shocking price this week: $15,900 before insurance.… Continue Reading New Postpartum Depression Drug Costs Nearly $16,000

Senator launches new models to manage costs of weight-loss drugs like Ozempic

Senator launches new models to manage costs of weight-loss drugs like Ozempic

WASHINGTON With blockbuster sales of Novo Nordisks Wegovy and Ozempic and the approval of a new rival this week, everyone in Washington is thinking about how to deal with the surging tide of weight-loss drug costs. Explosive national demand for weight management therapies and diabetes drugs like Ozempic, all of… Continue Reading Senator launches new models to manage costs of weight-loss drugs like Ozempic

Jamie Burton’s Column: The ACA’s Role in Managing Health Care Costs Before Medicare

Jamie Burton's Column: The ACA's Role in Managing Health Care Costs Before Medicare

Access to affordable health care has long been a concern for individuals in the United States, particularly before reaching Medicare eligibility age. The Affordable Care Act, signed into law in 2010, brought significant changes to the health care landscape, providing critical solutions to those who were not yet eligible for… Continue Reading Jamie Burton’s Column: The ACA’s Role in Managing Health Care Costs Before Medicare

Despite rising medical inflation, employers continue to protect workers from costs

The costs of everything have increased in recent years, including health services and, therefore, insurance coverage for health care as well. Medical inflation constitutes a real challenge and pushes American companies to innovate to continue to offer their employees much-appreciated health coverage. Employers continue to offer robust and affordable employer-sponsored… Continue Reading Despite rising medical inflation, employers continue to protect workers from costs

The role of Medicare benefits in reducing health care costs differs by patient condition

The role of Medicare benefits in reducing health care costs differs by patient condition

According to a new study by Professor Jeah Jung, Medicare Advantage generally used fewer resources (and therefore cost less), but to varying extents across conditions, including in some cases where it was not significantly different from traditional Medicare. More than 18 percent of the U.S. population ($65 million) is enrolled… Continue Reading The role of Medicare benefits in reducing health care costs differs by patient condition